Fundraising FoxNeuro-Bio
1 known investors
Find your way into Neuro-Bio
Sign up to see every warm intro you have to Neuro-Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Neuro-Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Neuro-Bio is a privately owned biotech focused on neurodegenerative diseases, developing diagnostic and therapeutic strategies for Alzheimer's disease. Its work centers on a novel molecule, T14, identified as a driver of neurodegeneration, to build a pre-symptomatic biomarker and drug.
Investors · 1
Funding
SEC filings, press & company announcements- Undisclosed amountSeries CMar 2023Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Neuro-Bio do?
- Neuro-Bio is a privately owned biotech focused on neurodegenerative diseases, developing diagnostic and therapeutic strategies for Alzheimer's disease. Its work centers on a novel molecule, T14, identified as a driver of neurodegeneration, to build a pre-symptomatic biomarker and drug.
- Who are Neuro-Bio's investors?
- Neuro-Bio's investors include Kairos Venture Investments, Llc.